Search Results
Feb 17, 2026, 08:42 ET Stella Mental Health Expands Boston-Area Services with New Newton Clinic as Chief Psychiatric Officer Dr. Brian Boyle Selected as 2026 National SPRAVATO® Bureau Speaker
Psychotherapy and the Program in Psychodynamics, and completed fellowship training at the Boston Psychoanalytic Society and Institute. He earned his MD from Harvard Medical School and an honors degree in philosophy from Yale College and is also affiliated with Two Brattle Center.Stella Mental
More news about: Stella Mental Health
Feb 17, 2026, 08:39 ET Vampire Wing Lift® Addresses "Ozempic Vulva": Weight Loss Drugs Spotlight a 16-Year-Old Solution
the volume loss, laxity, dryness, and discomfort that can follow rapid fat reduction in the vulvar tissues. According to Dr. Charles Runels, MD, President of the Cellular Medicine Association (CMA) and inventor of the
More news about: Cellular Medicine Association
Feb 17, 2026, 08:35 ET The American Diabetes Association Announces 2026 Pathway to Stop Diabetes Grant Recipients
year, Pathway grants have been awarded to the following researchers and their breakthrough projects:Christina Astley, MD, ScD, Assistant Professor of Pediatrics, Harvard Medical School, and Assistant in Pediatrics, Boston Children's HospitalDr. Astley's
More news about: American Diabetes Association
Feb 17, 2026, 08:35 ET Retia Medical Receives FDA 510(k) Clearance for Argos Infinity™, Expanding Cardiovascular Intelligence Across High-Risk Surgical and Critical Care Environments
even more essential."In high-risk patients, deterioration can begin before traditional vital signs clearly reflect it," said Chiedozie Udeh, MD, MHEcon, MBA, FCCM, FASA, Professor of Anesthesiology and Medical Director, Cleveland Clinic eHospital. "By analyzing the monitoring data we already collect,
More news about: Retia Medical
Feb 17, 2026, 08:33 ET Cyrano Therapeutics Announces Positive Topline Results from Phase 2 FLAVOR Trial of CYR-064, a Proprietary and Potential First-to-Market Regenerative Therapy for Persistent Smell Loss
today.""We now have the first randomized clinical trial data evaluating a targeted regenerative therapy for post-viral smell loss," said Mas Takashima, MD, FACS, Chairman of the Department of Otolaryngology - Head and Neck Surgery at Houston Methodist Hospital and Primary Investigator for the FLAVOR trial.
More news about: Cyrano Therapeutics
Feb 17, 2026, 08:00 ET Mepolizumab May Be Protective Against Small Airway Disfunction Exacerbation Risks in Children
placebo group, indicating a potential protective effect of anti-IL5 therapy in children with small airway dysfunction," said co-author Courtney Gaberino, MD.Within the study, 271 participants, aged 6-17 years old, with exacerbation-prone asthma and blood eosinophils >=150/microliter, were randomized
More news about: American Academy of Allergy, Asthma & Immunology (AAAAI)
Feb 17, 2026, 08:00 ET GelMEDIX Completes $13 Million Seed Financing and Announces First Partnership
GA."GelMEDIX was co-founded by leading experts in biomaterials, ophthalmology, and regenerative medicine, including:Reza Dana, MD, MPH, MSc: Claes H. Dohlman Professor of Ophthalmology, Harvard Medical School; Director, Harvard-Vision Clinical Scientist Development Program; and
More news about: GelMEDIX
Feb 17, 2026, 07:57 ET Infosys Unveils AI First Value Framework: Uniquely Positioned to Capture New AI Services Opportunity of Over $300 Billion
orchestrate AI across complex ecosystems and unlock significant value from the expanding global AI services opportunity."Salil Parekh, CEO and MD, Infosys, said, "We see AI as a powerful enabler for the services industry and our AI First value framework uniquely positions Infosys to capture
More news about: Infosys
Feb 17, 2026, 07:49 ET Infosys Unveils AI First Value Framework: Uniquely Positioned to Capture New AI Services Opportunity of Over $300 Billion
orchestrate AI across complex ecosystems and unlock significant value from the expanding global AI services opportunity."Salil Parekh, CEO and MD, Infosys, said, "We see AI as a powerful enabler for the services industry and our AI First value framework uniquely positions Infosys to capture
More news about: Infosys
Feb 17, 2026, 07:00 ET Levee Medical Completes Oversubscribed $12M+ Financing to Support PMA as ARID II Trial Progresses
prostatectomy."Yesterday we hosted ARID II principal investigator, Dr. Scott Eggener, Chair of Urology at UCLA, who is our 40th surgeon to participate," said Ahmed Ghazi, MD, Professor of Urology at Johns Hopkins and Director of the Surgical Learning and Innovation Center of Excellence. "Our goal is to mobilize leadership
More news about: Levee Medical
Feb 17, 2026, 07:00 ET Ceva Highlights Breakthrough Year for AI Licensing and Physical AI Adoption in 2025
ROCKVILLE, Md., Feb. 17, 2026 /PRNewswire/ -- Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP for the smart edge, today announced that 2025 marked a breakthrough year for its artificial intelligence
More news about: Ceva, Inc.
Feb 17, 2026, 07:00 ET Ceva, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results
ROCKVILLE, Md., Feb. 17, 2026 /PRNewswire/ -- Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP for the Smart Edge, today announced its financial results for the fourth quarter and full year ended December
More news about: Ceva, Inc.
Feb 17, 2026, 06:44 ET Medtronic announces first surgery with Hugo™ robotic-assisted surgery system in the U.S. performed at Cleveland Clinic
commercial surgical case using its recently FDA-cleared Hugo™ robotic-assisted surgery (RAS) system has been successfully performed by Jihad Kaouk, MD, professor and chair of the Glickman Urologic Institute and the Zegarac-Pollock Endowed Chair in Robotic Surgery at Cleveland Clinic.Dr. Kaouk
More news about: Medtronic plc
Feb 17, 2026, 06:00 ET Realtor.com® Rent Report: U.S. Rental Market Now Firmly Renter-Friendly as Vacancy Rate Climbs to 7.6%
Baltimore-Columbia-Towson, Md.$1,816
More news about: Realtor.com
Feb 17, 2026, 06:00 ET Leidos Posts Strong Fourth Quarter and Fiscal Year 2025 Results
Air Base Air Defense - Missile Defense (ABADS-MD). The Air Force awarded Leidos a five-year, $2.2 billion award to deploy its Affordable Long-Range Persistent Surveillance (ALPS) and Medium-Range Air Defense Radar (MRADR) systems in support of the ABADS-MD program. These systems fulfill the Department
More news about: Leidos Holdings, Inc.
Feb 17, 2026, 00:50 ET NPCI International tandatangani perjanjian dengan Payments Network Malaysia agar UPI dan DuitNow diterima di India dan Malaysia
berbagai tempat usaha lainnya. Turis Malaysia di India bisa membayar dengan menggunakan UPI QR di jutaan tempat usaha di India.Kata Ritesh Shukla, MD & CEO NPCI International, "Di bawah bimbingan Pemerintah India dan Reserve Bank of India, kami ingin memperluas jangkauan global UPI dengan
More news about: NIPL
Feb 16, 2026, 20:37 ET Mazda Foundation Awards $586,361 in 2026 Grants, Deepening Long‑Standing Commitments to Food Security, Education, and Workforce Development
readiness.Mazda Foundation's workforce development portfolio in 2026 reflects a blend of legacy partners and new collaborations. Vehicles for Change (Halethorpe, MD) and Bracken's Kitchen (Garden Grove, CA) return as key partners helping individuals build job skills and secure sustainable employment. New partnerships
More news about: Mazda North American Operations
Feb 16, 2026, 14:51 ET CPP Announces Partnership with Silva MD Anti-Aging & Wellness
Silva MD Anti-Aging & Wellness, founded and led by Melinda Silva, MD, ABAARM, FAARM, a Board-Certified Physician in Integrative and Regenerative Medicine.
More news about: Cosmetic Physician Partners
Feb 16, 2026, 12:00 ET Rapidise Accelerates into a Global Electronics Powerhouse with 10X Revenue Growth and Expanding International Footprint
growth."Our growth over the past year reflects a structural shift in how global customers perceive Indian ODMs" said Brijesh Kamani, CEO & MD at Rapidise. "We are building Rapidise as a platform-driven organization that combines deep engineering expertise, scalable manufacturing, and consistent
More news about: Rapidise Technology Pvt. Ltd.
Feb 16, 2026, 10:56 ET No More Waiting: MY DR NOW Opens New Oro Valley Clinic
patients consistent access to a primary care team."The traditional health care model is broken, and people are tired of waiting," said Payam Zamani, MD, founder and CEO of MY DR NOW. "Patients should not need to wait months just to see their family doctor. At MY DR NOW, patients are seen when they want,
More news about: MY DR NOW
Feb 16, 2026, 10:45 ET InventHelp Inventor Develops New Whistle Design (BDH-1036)
whistle calls at a field or sporting facility where multiple games or practices are happening at the same time," said an inventor, from Ellicott City, Md., "so I invented the WHISTLE. My design enables players and spectators to hear the sound of their coach's whistle easily and distinctly."
More news about: InventHelp
Feb 16, 2026, 10:30 ET InventHelp Inventor Develops Fun and Stress-Relieving Game (BDH-418)
Feb. 16, 2026 /PRNewswire/ -- "I wanted to create a fun game that could also help relieve stress," said an inventor, from Glen Burnie, Md., "so I invented the FOUND IT/ NEEDLE IN A HAYSTACK. My design would take focus and a bit of skill, which could help take your mind off stressful work
More news about: InventHelp
Feb 16, 2026, 10:00 ET Urgent Call from Neurologists: Strengthen Epilepsy Diagnosis and Increase Monitoring Capacity
Daniel Friedman, MD (Chair)Greogry K. Bergey, MD, FAAN, FANA, FAES, FAAASTanya Kehoe, PA-C, OTR/LMohamad Koubeissi, MD, MA, FAAN, FANA, FAESJohn Stern, MD, MA, FAAN, FANA, FAESStatement from expert panelist Daniel Friedman, MD "Accurate
More news about: Clinical Neurological Society of America
Feb 16, 2026, 09:00 ET Data Presented at SABCS 2025 Demonstrated that the Endocrine Activity Index® (EAI®) May Identify Patients Most Likely to Benefit from Extended Endocrine Therapy
HER2-negative breast cancer who may derive meaningful benefit from extended endocrine therapy. The findings were presented by Eleftherios P. Mamounas, MD, AdventHealth Cancer Institute, Orlando, FL, in a general session on behalf of the NRG Oncology/NSABP investigators, under the title: "Evaluation of the
More news about: Delphi Diagnostics Inc
Feb 16, 2026, 08:38 ET World Neuroscience Day Conference Returns February 21, 2026, 8:00 AM.
neuroscience, and community partners for a day of education, empowerment, and innovation. This year's keynote will be presented by Dan Sorescu, MD, Associate Professor of Medicine, Emory University School of Medicine. "Reuniting the Mind with the Heart" explores one of the most powerful and
More news about: Atlanta Neuroscience Institute and Foundation